Recommended Readings: Irving Weissman, M.D.

Friday Lecture Series

The Philip Levine Memorial Lecture

Normal and Neoplastic Stem Cells

Irving Weissman, M.D., director,

Institute of Stem Cell Biology and Regenerative Medicine;

V&D Ludwig Professor of Clinical Cancer Research; and professor, departments of

developmental biology, pathology and neurosurgery and biology,

Stanford University School of Medicine

November 1, 2013

3:45 p.m.-5:00 p.m. (Refreshments, 3:15 p.m., Abby Lounge)

Caspary Auditorium

Recommended Readings

Chao, M. P., Majeti, R., & Weissman, I. L. (2012). Programmed cell removal: A new obstacle in the road to developing cancer. Nature Reviews Cancer, 12(1), 58-67

Jan, M., Snyder, T. M., Corces-Zimmerman, M. R., Vyas, P., Weissman, I. L., Quake, S. R., & Majeti, R. (2012). Clonal evolution of preleukemic hematopoietic stem cells precedes human acute myeloid leukemia. Science Translational Medicine, 4(149)

Lu, R., Neff, N. F., Quake, S. R., & Weissman, I. L. (2011). Tracking single hematopoietic stem cells in vivo using high-throughput sequencing in conjunction with viral genetic barcoding. Nature Biotechnology, 29(10), 928-934

Pang, W. W., Pluvinage, J. V., Price, E. A., Sridhar, K., Arber, D. A., Greenberg, P. L., . . . Weissman, I. L. (2013). Hematopoietic stem cell and progenitor cell mechanisms in myelodysplastic syndromes. Proceedings of the National Academy of Sciences of the United States of America, 110(8), 3011-3016

Pang, W. W., Price, E. A., Sahoo, D., Beerman, I., Maloney, W. J., Rossi, D. J., . . . Weissman, I. L. (2011). Human bone marrow hematopoietic stem cells are increased in frequency and myeloid-biased with age. Proceedings of the National Academy of Sciences of the United States of America, 108(50), 20012-20017

Uchida, N., Chen, K., Dohse, M., Hansen, K. D., Dean, J., Buser, J. R., . . . Back, S. A. (2012). Human neural stem cells induce functional myelination in mice with severe dysmyelination. Science Translational Medicine, 4(155)

Weissman, I. (2012). Stem cell therapies could change medicine… if they get the chance. Cell Stem Cell, 10(6), 663-665


Comments are closed.